Go to Article
Excerpt from www.cidrap.umn.edu
Pediatric patients hospitalized with severe COVID-19 or the related multisystem inflammatory syndrome in children (MIS-C) experience new neurologic problems and/or impaired function at rates of 18.0% and 24.8%, respectively, an international group of researchers suggests in JAMA Network Open.
In a secondary analysis of the Global Consortium Study of Neurologic Dysfunction in COVID-19 study, investigators studied the rates of new severe neurologic conditions among 3,568 COVID-19 or MIS-C patients younger than 18 years hospitalized from January 2020 to July 2021 at 46 centers in 10 countries. The Pediatric Cerebral Performance Category scale was used to define new neurocognitive disorders, and the Functional Status Scale determined functional impairment.
About The Author
